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Widespread nasal carriage of Mycobacterium leprae among a healthy 
population in a hyperendemic region of northeastern Brazil
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A case-control study was conducted to determine the presence of Mycobacterium leprae DNA in nasal secretions 
of leprosy cases and nonleprosy individuals in Fortaleza, Brazil. It included 185 cases identified by physicians at the 
Dona Libânia National Reference Centre for Sanitary Dermatology (CDERM). A control group (Co) (n = 136) was 
identified among individuals from CDERM not diagnosed as leprosy cases. To augment the spatial analysis of M. le- 
prae specific repetitive element (RLEP) positive prevalence, an external group (EG) (n = 121), a convenience sample of 
healthy students, were included. Polymerase chain reaction for the RLEP sequence was conducted for all participants. 
Prevalence of RLEP positivity for cases and Co were 69.2% and 66.9%, respectively, significantly higher than for EG 
(28.1%), and reported elsewhere. Male sex, belonging to a lower socioeconomic status (D/E), history of a previous con-
tact with a case and being older, were associated with being a leprosy case. Our geographical analysis demonstrated 
that the bacillus is widespread among the healthy population, with clusters of RLEP positive multibacillary cases con-
centrated in distinct areas of the city. Our results suggest that in endemic areas, as in Fortaleza, surveillance for both 
nonhousehold leprosy contacts and members of the general population living in cluster areas should be implemented.
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In the last 20 years, programs for global leprosy 
control made real progress, with over 14 million people 
cured of the disease through multidrug therapy (MDT). 
Although this correlates with a reduction of over 90% in 
the prevalence rate, transmission still occurs with about 
250,000 new cases of leprosy still being reported annu-
ally, concentrated in a few countries (WHO 2014). Clus-
ters of high endemicity still remain in Angola, Brazil, 
the Central African Republic, India, Madagascar, Nepal 
and the United Republic of Tanzania and in previously 
highly endemic countries, such as the Democratic Re-
public of the Congo and Mozambique.
Brazil reported a 65% reduction in the prevalence 
from 2002-2012, from 4.33 in 2002 to 1.51 cases/10,000 
in 2012. Despite this achievement, a few regions in Bra-
zil are still considered endemic, including the North, 
Northeast and Central-West. A second issue is the re-
ported number of cases in children less than 15 years 
of age. Of total cases from 2012, 2,246 (7%) of them 
were younger than 15, resulting in a high detection rate 
of 17.2/10,000 in this population (tabnet.datasus.gov.br/
cgi/deftohtm.exeidb2012/d0206.def).
The state of Ceará (CE) is located in northeastern 
Brazil. In 2013, 87.5% (161/184) of municipalities in CE 
diagnosed new cases of leprosy, 20.6% had more than 10 
new cases and 12.5% are classified as hyperendemic and 
recorded over 40 new cases per 100,000 inhabitants. For-
taleza, the state capital, reported 689 cases in the same 
year, which represents an incidence rate of 27.2 cas-
es/100,000 inhabitants. Even though ≥ 80% of household 
contacts of cases should be examined as part of leprosy 
control activities, only 52.3% of contacts were examined 
in Fortaleza in 2013. Since 5.9% of the total cases report-
ed annually in the state still occur among those less than 
15 years of age or younger one could argue that active 
leprosy transmission is ongoing in CE (SESA 2014).
Mycobacterium leprae identification is difficult due 
to the inability of the bacillus to grow in vitro, thus lep-
rosy diagnosis is based on microscopic detection of the 
bacilli combined with clinical assessment. DNA studies 
using polymerase chain reaction (PCR) have been used 
for the molecular diagnosis of M. leprae (Santos et al. 
1999, Job et al. 2008). The literature describes several 
genomic target sequences specific for M. leprae that have 
been used in PCR or as DNA probes, including the genes 
encoding the 36-kDa antigen, 18-kDa antigen, 16S rRNA 
and the repetitive element sequences of M. leprae (Par-
kash et al. 2004, Martinez et al. 2009, Davis et al. 2013).
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PCR has shown high sensitivity and specificity. It is 
able to detect 100% of multibacillary (MB) and 34-80% 
paucibacillary (PB) cases in nasal secretions (Scollard 
et al. 2006). It is also able to detect nucleic acid of M. 
leprae in 5-12% and 1-2% of the contacts of MB and 
PB cases, respectively (Banerjee et al. 2010). Contacts of 
a leprosy case from endemic regions are putative carri-
ers of M. leprae bacilli. Surveillance of the contacts and 
known cases can identify new cases, lead to treatment 
and prevent new cases.
This study has two aims: first, to document the pres-
ence of M. leprae DNA in nasal secretion of leprosy 
cases and nonleprosy individuals and, second, to discuss 
the role of geographic location in the epidemiology of 
leprosy in Fortaleza.
SUBJECTS, MATERIALS AND METHODS
Settings - Fortaleza is divided into six administrative 
regions (I-VI). Region II presents the highest mean fam-
ily income in Fortaleza (average monthly income = US$ 
911 in mid-2012 adjusted dollars) and the lowest leprosy 
incidence. Region V (average monthly income = US$ 
232) presents the lowest mean family income and high-
est leprosy incidence (IPECE 2014). A cross-sectional 
study was conducted from June 2009-December 2010.
Subjects - During the period of the study, 837 new lep-
rosy cases living in Fortaleza were diagnosed by trained 
dermatologists of the Dona Libânia National Reference 
Centre for Sanitary Dermatology (CDERM). Since re-
cruitment was conducted two days per week (December, 
January, July and holidays had reduced recruitment), 185 
leprosy cases, identified as C, were included and con-
firmed by clinical skin examination, skin smear and bi-
opsy. They were classified using Ridley-Jopling criteria 
(Ridley & Jopling 1966) based on histology and bacte-
rial indexes (BI). Controls (Co) (n = 136) were patients 
attending in CDERM for other clinical dermatological 
conditions such as psoriasis, skin cancer or aesthetic 
blemishes and were not diagnosed with leprosy. Nasal 
samples were collected for all participants of the study.
In order to explore the role of geographic location 
and social class in the epidemiology of leprosy in For-
taleza and in response to the high overall rate and poten-
tial for laboratory contamination of samples producing 
this high rate, we included an external group (EG) (n 
= 121) of medical students in the 1st year class of a pri-
vate medical school, who reported no history of a pre-
vious contact with a leprosy case. Their samples were 
collected at the same time of the year using the same 
methodology applied to other participants. We compared 
this group - living in a geographically separate, high so-
cioeconomic status (SES) area of Fortaleza (region II) 
- with the C and Co participants who live in poorer areas 
of the city (regions V and I). Average income in region 
II is 15.3 times higher than in region V (IPECE 2014). 
Leprosy prevalence in region V is more than four times 
higher than in region II (1.4 vs. 0.3 cases/10,000 inhabit-
ants) in 2014 (Geluk et al. 2012). Throughout this article 
the EG is treated as a separate population, i.e., not a Co 
group. C and Co participants completed a questionnaire 
to collect demographic, socioeconomic (ABEP 2014), 
environmental and behavioural data.
Laboratory methods - Nasal samples were obtained 
from all participants by gently rubbing a nasal swab 
previously wetted with Tris-EDTA buffer (pH 8.0) in 
the vestibule on each side of the nose. After collection, 
each swab was immersed in a sterile and labelled tube 
and stored at -20ºC until processing. Briefly, each swab 
was directly cut and collected in a previous labelled 
tube with 1 mL of 4% NaOH and the remaining Tris-
ethylenediamine tetraacetic acid (EDTA) buffer. After 
centrifugation for 20 min at 2,500 rpm, 0.6 mL of lysis 
buffer (10 mM Tris-HCl, 10 mM EDTA, 50 mM NaCl, 
2% w/v sodium dodecyl sulfate and 0.3 mg/mL protein-
ase K) was added and the tube was left under incubation 
for 18 h at 56ºC. Phenol-chloroform-isoamyl alcohol (0.6 
mL, 25:24:1) was added and the tube was homogenised 
by inversion. After centrifugation for 5 min, the aqueous 
phase was collected and mixed with an equal volume of 
chloroform. After another brief centrifugation, the upper 
phase was collected and the DNA was then precipitated 
with 2.5 mM NaCl and isopropanol. The precipitated 
DNA was finally eluted in 70 µL of dH2O.
To detect the M. leprae DNA, three primers were 
devised, which comprised outer and inner nested pairs 
based on the M. leprae-specific repetitive element 
(RLEP)2 (X17152). The primers RLEP1 (5’-ATATC-
GATGCAGGCGTGAG-3’) and RLEP2 (5’-GGAT-
CATCGATGCACTGTTC-3’) were used to amplify a 
282-bp fragment and the inner primer RLEP3 (5’-GGG-
TAGGGGCGTTTTAGTGT-3’) and outer primer RLEP2 
to amplify a 238-bp fragment. In order to confirm the 
results, a separate PCR reaction was conducted using a 
set of primers targeting the RNA polymerase sigma fac-
tor (rpoT - Q59532) of the M. leprae DNA. It generated 
a fragment of 91-bp (Matsuoka et al. 2000) (forward: 
5’-ATGCCGAACCGGACCTCGACGTTGA-3’ and re-
verse: 5’-TCGTCTTCGAGGTCGTCGAGA-3’). Signifi-
cantly, both primer sets presented the same melting tem-
perature. Therefore, the PCR amplification conditions 
for both fragments were the same as described below.
Illustra PuRe Taq Ready-To-GoTM PCR Beads pre-
dispensed in 0.25 mL tubes (GE Healthcare) were used 
in the PCR reaction. Reaction mixtures (25 µL) were pre-
pared by adding 50 nM of each primer (Life Technologi-
esTM) and 5 µL of the purified DNA from nasal samples 
to each tube containing a PCR bead. For the second reac-
tion, 0.5 µL of the PCR product was used as a template. 
The mixture for both reactions was cycled through the 
following temperature profile: 94ºC for 5 min followed 
by 40 cycles at 94ºC for 30 s, 59.5ºC for 30 s and 72ºC 
for 1 min. The reaction mixture was held at 4ºC before 
electrophoresis of the products. In each run, a positive 
control of 20 pg of chromosomal M. leprae DNA was in-
cluded, as was a negative control without target DNA. All 
incubations were performed in the same thermal cycler.
After amplification was finished, the reaction mix-
ture was run in a 2% agarose gel. After electrophoresis, 
the gel was stained with ethidium bromide solution and 
the fragments were examined under the ultraviolet il-
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lumination. The PCR products were purified using the 
QIAquick PCR Purification Kit prior to sequencing in 
an Applied Biosystems DNA sequencer (Perkin-Elmer 
Applied Biosystems) using a BigDye Terminator Cycle 
Sequencing kit. The sequences were identified using 
SecScape software v.2.7 (Applied Biosystems). A refer-
ence RLEP2 sequence (GenBank accession NC002677) 
was used to align the sequences.
All procedures were conducted by the same tech-
nician and used the same methods. False-positive am-
plifications were addressed by using individual sterile 
section-cutting blades for swab cutting and sterile glass-
ware for each swab sample. Physical separation of the 
areas for the handling of samples, PCR preparation and 
PCR analysis was assiduously maintained throughout 
the study. The swab samples and extracted DNA sam-
ples were carefully identified and kept in separate boxes.
Statistical analysis - Data were entered in a spread-
sheet using Microsoft Excel 2011 for Mac (Microsoft 
Corp, USA) and transferred to SPSS 16.0 statistical soft-
ware (SPSS Inc, USA). A bivariate analysis for all vari-
ables of interest was performed for the case and control 
data. The chi-square test and Fisher’s exact two-tailed 
test analysis was performed and differences were con-
sidered significant at values of p < 0.05. Stata v.12.0 (Sta-
ta Corp, USA) was also used to further analyse the data. 
Variables with p value < 0.20 were included into a logis-
tic regression analysis in order to investigate if RLEP 
PCR positivity can predict cases and controls adjusting 
for other studied variables. Variables with p value < 0.05 
were kept in the final model (age, sex, SES and history 
of a previous contact with a leprosy case). For logistic re-
gression the forward stepwise method and Wald statistic 
were used. PCR was kept in the model as an independent 
variable to emphasise that it is not related to C and Co.
Spatial analysis - We conducted a spatial analysis of 
RLEP positive prevalence in nasal secretion in the three 
groups (C, Co and EG). All participants were geolocated 
using Google Earth software and a database of street 
network files. The coordinates were transcribed to the 
Excel spreadsheet and subsequently transformed into 
PDF files to be used directly in the Geographic Infor-
mation System application ArcGIS 9.3 (Environmental 
Systems Research Institute, USA). After the data had 
been formatted in spreadsheets, ArcMap was used to il-
lustrate the spatial distribution of cases and controls in 
Fortaleza. Population densities were generated using the 
Spatial Analyst extension - kernel density, using a 20 km 
search radius and a grid size of 2.5 km.
Ethics - All participants signed an informed consent 
form and authorised the collection of samples. This proj-
ect was approved by the CDERM Ethical Committee 
(protocol 011/07) and guidelines of the Ethical Commit-
tee were followed in conducting the research.
RESULTS
Among the 185 leprosy cases, 89 were of borderline 
clinical form, 37 were tuberculoid, 44 were lepromatous 
and 9 were indeterminate. Six cases were not classi-
fied according to their clinical form. Men predominated 
among C (p < 0.0001) (data not shown). The age of cases 
ranged from 4-81 years, similar to Co (4-69 years old), but 
the overall mean age of the C (40.3 years) was higher than 
the Co (29.1 years; p < 0.0001). In the amplification analy-
sis of RLEP with PCR, 69.2% of cases were positive, with 
a similar result seen among Co (66.9%; p = 0.7163) (Table 
I). For the EG ages (data not shown) ranged between 18-
31 years (61.2% females and 38.8% males) and the preva-
lence of RLEP positive among the EG was 28.1%.
Educational level, SES and presence of Bacillus 
Calmette-Guérin (BCG) scar were included in the study. 
Educational level is traditionally used as an indicator of 
SES in Brazil. Individuals with a lower educational level 
(< 4 years of schooling) had a higher risk of developing 
leprosy [59.5% vs. 41.2%; p < 0.0001, odds ratios (OR) 
= 3.036]. A similar trend was found for cases with low 
incomes; SES D/E was more common among leprosy 
cases compared to the Co individuals (67% vs. 39%; p 
< 0.0001, OR = 3.183). In addition, a higher risk for de-
veloping leprosy was found for those whose head of the 
family had a lower level of education (69% vs. 43.2%; p 
< 0.0001, OR = 2.929). Among the leprosy cases, the ab-
sence of BCG scar was significantly higher compared to 
the Co group (36.1% vs. 20.5%; p = 0.0037, OR = 2.198). 
History of a previous contact with a leprosy case was re-
ported to 61.6% and 33.8% of the C and Co, respectively 
(p < 0.0001, OR = 3.141) (Table I).
Positivity by clinical classification is presented in 
Table II. We observed no difference in PCR positiv-
ity related to the different clinical forms. However and 
as expected, we observed a strong positive correlation 
between DNA detection in nasal swabs for the leprosy 
cases and the BI (78.8%, p = 0.026).
A multivariate logistic regression examined the risk 
factors associated to leprosy cases and controls adjust-
ing for all the other variables with p < 0.20, including 
being positive to M. leprae DNA in nasal secretion. Be-
ing older {OR = 1.048 [(95% confidence interval (CI) 
1.029-1.068]}, male [OR = 6.240 (95% CI 3.356-11.601)], 
belonging to a lower (D/E) socioeconomic class [OR = 
3.347 (95% CI 1.906-5.879)] and reporting a history of 
previous contact with a leprosy case [OR = 3.859 (95% 
CI 2.206-6.752)] were more likely to be a leprosy case. 
Contrary to our hypothesis, being RLEP PCR positive 
was not found to be related to cases or controls [OR = 
1.062 (95% CI 0.594-1.897)] (Table III).
The geographical kernel density distribution of all 
members with M. leprae DNA positive in nasal secre-
tion in Fortaleza is illustrated in Fig. 1A. We observed 
that the groups C and Co were concentrated in the south-
west and western side of Fortaleza (Fig. 1B, C), areas of 
lower SES, while group EG is concentrated in clusters in 
the northeast region of the map (Fig. 1D), representing 
wealthier areas of the city. In addition, cases with a posi-
tive bacilloscopy and RLEP positive are also clustered 
(Fig. 2). The distance between the cases that comprised 
each cluster varied from 121-1,000 m.
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DISCUSSION
This study found a very high PCR positivity of 
RLEP DNA in nasal samples for both leprosy cases and 
their controls. These results are much higher than in en-
demic areas of Indonesia, 6.6% (Bakker et al. 2006) and 
7.8% (Klatser et al. 1993). However, results are similar to 
studies conducted in the Philippines (55%) (de Wit et al. 
1993) and Brazil (58.3%) (Patrocinio et al. 2005).
Our study showed that PCR positivity for controls 
was very similar to that of cases. Both populations in-
habit the poorest part of Fortaleza, but controls are ge-
olocated in bridging areas that connect the richest part 
of the city with the poorest area. CDERM is a public 
dermatology centre drawing mainly low-income pa-
tients that live in poorer areas of Fortaleza. These areas 
are hyperendemic for leprosy, present the lowest fami-
ly income and the worst general health indicators in the 
city (ABEP 2014, IPECE 2014, SESA 2014). Individuals, 
including both C and Co, work throughout the city and 
many of the poorest work as domestics and food han-
dlers in wealthy areas of the town. Additionally, while 
Co live in the same areas as C, the spatial analysis shows 
that they are more spread out geographically and some-
times overlap in areas where higher social status EG 
TABLE I
Risk factors related to leprosy cases (C) and controls (Co)
Variables
C
(n = 185) 
n (%)
Co
(n = 136) 
n (%) pa
OR 
(95% CI)
Sex
Male 99 (53.5) 33 (24.3) < 0.0001 3.593
(2.208, 5.847 )
Female 86 (46.5) 103 (75.7) - 1.000
Age (years)
Mean (range) 40.3 (4-81) 29.1 (4-69) < 0.0001b 1.045 
(1.029, 1.061 )
Mycobacterium leprae RLEP
PCR positive 219 (68.2%) 128 (69.2) 91 (66.9) 0.7163 1.110 
(0.691, 1.784)
PCR negative 102 (31.8%) 57 (30.8) 45 (33.1) - 1.000
Education (years)
< 4 110 (59.5) 56 (41.2) < 0.0001 3.036
(1.763, 5.227 )
4-8 42 (22.7) 29 (21.3) - 2.238
(1.175, 4.265 )
> 8 33 (17.8) 51 (37.5) - 1.000
Education of the head of the family (years)
< 8 118 (69.0) 57 (43.2) < 0.0001 2.929
(1.826, 4.701 )
> 8 53 (31) 75 (56.8) - 1.000
Socioeconomic status
B/C 61 (33) 83 (61) < 0.0001 1.000
D/E 124 (67) 53 (39) - 3.183
(2.007, 5.049 )
BCG scar
Yes 115 (63.9) 105 (79.5) 0.0037 1.000
No 65 (36.1) 27 (20.5) - 2.198
(1.306, 3.701 )
History of a previous contact with a leprosy case
Yes 114 (61.6) 46 (33.8) < 0.0001 3.141
(1.978, 4.989 )
No 71 (38.4) 90 (66.2) - 1.000
a: Fisher exact test; b: Mann Whitney U test; CI: confidence interval; OR: odds ratio; PCR: polymerase chain reaction; RLEP: 
M. leprae-specific repetitive element.
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live. Thus, active bacilli transmission between these two 
groups might occur in several settings. Detection of the 
bacilli may be demonstrated in studies among contacts 
showing rates of positivity ranging from 1.7-23% (de Al-
meida et al. 2004, Nagao-Dias et al. 2007, Banerjee et al. 
2010, Custodio et al. 2012).
Since the primary site of infection with M. leprae as 
a result of airborne infection is via the nose, PCR assays 
have been used to detect leprosy in nasal secretions in 
endemic communities. While a positive PCR from nasal 
mucosa do not differentiate a contact from a case in an 
endemic area, it does offer the opportunity to follow-up 
PCR positive individuals to identify new cases. Interest-
ingly, Martins et al. (2010) report that many people dis-
covered with PCR positive nasal secretions also report a 
nonspecific rhinopathy.
This study showed the bacilli are found in cases and 
controls with no statistical difference between the two 
groups. This means that individuals only will develop the 
disease if there is an association with other risk factors, 
including socioeconomic and demographic conditions, 
previous contact with a leprosy case and BCG status.
Our data show a statistical age difference among cas-
es and controls. At the same time there was no difference 
between the proportions of leprosy carriage among the 
two groups. Is important to note that for each year of age 
the chance to become a case increases exponentially 5% 
per year, after adjusting for all the other studied varia-
bles. Age has been previously found to be a risk factor for 
leprosy in CE (Frota et al. 2010). Leprosy has a long in-
cubation period - usually two-seven years - and therefore 
cases tend to be older than healthy individuals (Kerr-Pon-
tes et al. 2004). In an endemic region, the age difference 
reflects the time that an individual can be exposed to the 
bacillus and the risk to later develop the disease.
The EG group showed the lowest rate of positives. The 
different detection rates found in groups Co and EG are 
associated with differences in the SES of the members of 
the groups. While participants of Co are mostly people 
with low SES and living in poorer areas of the city, EG 
are members of high-income families (Fig. 1). Despite the 
lower PCR positivity in EG, levels reported are higher 
than published previously (de Almeida et al. 2004, Nagao-
Dias et al. 2007, Banerjee et al. 2010, Custodio et al. 2012). 
Moreover, studies indicate that contacts of leprosy cases 
that are nasal PCR positive have a higher risk of develop-
ing the disease (Douglas et al. 2004, Bakker et al. 2006).
Since Fortaleza is a leprosy endemic area, we postu-
late that Co acquires the bacilli from C and becomes a 
healthy nasal carrier that silently, but actively transmits 
the M. leprae to the EG individuals. In agreement with 
our findings, previous studies have shown that individu-
als may be exposed to a source of infection from carriers 
who harbour bacilli in their nose even for a short period 
of time (Patrocinio et al. 2005, Araújo et al. 2012). As 
seen in Fortaleza and other places, PB cases probably ac-
count for a significant part of the transmission in endem-
ic communities (Beyene et al. 2003, Martins et al. 2010).
In the geographic distribution analysis of PCR posi-
tivity among the cases with a positive bacilloscopy index 
in Fortaleza, individuals were found clustered in certain 
small areas. As expected, the areas surrounding those 
clusters were found to have a significantly higher con-
centration of leprosy cases. These data suggest that MB 
cases harbouring M. leprae in nasal cavities could be a 
major potential pathway for transmission of the bacillus 
within the population.
Among RLEP positives, we found men more likely 
to be cases and women to be controls (57.8% vs. 78%, 
OR = 4.865; 95% CI, 2.650-8.932; data not shown). In the 
context of multivariate analysis, we found men 6.24 more 
likely to be a case than women, but PCR was not found to 
be related to being a case. In a cohort study (Bakker et al. 
TABLE II
Leprosy cases by bacilloscopy index and  
Ridley-Jopling clinical classification
Variables
PCR+
 n (%)
PCR-
 n (%) pa
OR 
(95% CI)
Bacilloscopy index
Positive 67 (78.8) 18 (21.2) 0.0260 2.233
(1.121, 4.451)
Negative 50 (62.5) 30 (37.5) - 1
Clinical classification
Borderline 58 (65.2) 31 (34.8) 0.3746 -
Tuberculoid 27 (73) 10 (27) - -
Lepromatous 34 (77.3) 10 (22.3) - -
Indeterminate 5 (55.6) 4 (44.4) - -
a: Fisher exact test; CI: confidence interval; OR: odds ratio; 
PCR: polymerase chain reaction.
TABLE III
Logistic regressiona to access risk factors  
associated with leprosy cases (C) and controls (Co)
Factors pa
Cases
OR
(95% CI)
Age (years)b < 0.001 1.048
(1.029, 1.068)
Male sexb < 0.001 6.240
(3.356, 11.601)
Socioeconomic status
(D/E classb)
< 0.001 3.347 
(1.906, 5.879)
History of a previous
contact with a caseb
< 0.001 3.859
(2.206, 6.752)
PCRc 0.594 1.062
(0.594, 1.897)
a: Wald statistic; b: forward stepwise method adjusted to all 
variables in the model; c: polymerase chain reaction (PCR) 
was kept in the model to show it is not related to C and Co; OR: 
odds ratio; CI: confidence interval.
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Fig. 1: spatial kernel density of specific repetitive element (RLEP) polymerase chain reaction (PCR) positive of Mycobacterium leprae DNA 
from nasal samples. A: All RLEP PCR positivity studied individuals [cases (C), controls (Co) and external groups (EG)]; B: C; C: Co; D: EG.
Fig. 2: map of the city of Fortaleza, state of Ceará, Brazil, showing leprosy cases with bacilloscopy index positive and specific repetitive element 
(RLEP) polymerase chain reaction (PCR) from nasal samples. ●: leprosy cases with positive RLEP PCR; +: leprosy cases with negative RLEP PCR.
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2006) conducted in the Flores Sea Islands of Indonesia, 
it was shown that males have twice the risk of acquiring 
leprosy compared to women. A previous study using an-
ti-phenolic glycolipid (PGL)1 conducted by our group in 
other endemic areas of CE, also found a higher propor-
tion of seropositivity among men. In a separate paper in 
preparation using social network analysis we hypothesise 
that men have contact occurring at the work place.
The highest rate of PCR positivity was among the 
cases with positive bacilloscopy, as these individuals 
have a high bacillary load (high BI). However, there 
was no difference in PCR positivity among the different 
clinical forms of the disease. Other studies have found 
a higher PCR positivity in nasal secretion among the 
MB clinical form compared to the PB ones (Banerjee et 
al. 2010, Araújo et al. 2012). We hypothesise that M. le- 
prae is so widespread across the city that patients har-
bour not only their own bacilli, but also bacilli from mul-
tiple infections from other patients/carriers that they are 
exposed to. This may be one reason we cannot differen-
tiate nasal carriage by clinical form.
The BCG vaccine - originally used to protect against 
tuberculosis - has been shown to provide protection 
against leprosy. Most vaccinated seropositive con-
tacts who develop leprosy display the mildest form of 
the disease (PB) with negative serology for M. leprae 
(Rodrigues et al. 2007, Lobato et al. 2011). A negative 
association was found between subjects with BCG scar 
and cases. These results corroborate other studies that 
demonstrate the protection of BCG in leprosy preven-
tion (Kerr-Pontes et al. 2006, Zodpey 2007, Merle et al. 
2010). BCG improves the immunological response of 
leprosy cases by inducing the activation of the initial 
phase of immunocellular activity, innate human immu-
nity (increase in tumour necrosis factor alpha, interleu-
kin-12 and macrophage activation) (Zenha et al. 2012).
Several studies show a correlation between higher 
incidences of leprosy and lower SES (Kerr-Pontes et al. 
2006, Sales et al. 2011, Cury et al. 2012). In agreement 
with the literature, individuals belonging to socioeconom-
ic class D/E were found to be 3.35 times more at risk to be 
a leprosy case than controls. Lower SES is strongly relat-
ed to low educational achievement. In this study illitera-
cy and educational attainment of less than eight years of 
schooling for the head of household was associated with 
an increased chance of being a leprosy case. Low educa-
tional level has been reported as a risk factor for leprosy in 
studies conducted in CE (Kerr-Pontes et al. 2004, 2006).
PCR can be used to complement leprosy diagnosis 
and classification and can play a role in choosing the most 
appropriate treatment, thereby reducing the risk of dis-
ability and disease transmission. Using PCR, this study 
showed a high rate of positivity among the three groups, 
demonstrating many individuals colonised with M. le- 
prae in the upper airways that may be taking an active 
role in the transmission of leprosy. This study used the 
RLEP repetitive element sequence of M. leprae, which is 
reported to be specific for M. leprae and is not present in 
other mycobacterial or bacterial species (Wen et al. 2013). 
The RLEP-based PCR is capable of detecting M. leprae 
DNA in 73% of patients with a BI of 0 (Woods & Cole 
1989, Yoon et al. 1993). In addition, a nested PCR based 
on the RLEP region was shown to amplify 1 fg of puri-
fied DNA and was used to detect DNA in patients’ whole 
blood, with higher sensitivity and specificity (Wen et al. 
2013). All samples tested for RLEP sequence were also 
submitted to amplification with rpoT primers demonstrat-
ing an agreement in the results (Supplementary Figs 1-3). 
Since we used several strategies to minimise false-posi-
tive amplifications and contamination, we are confident 
that these are valid data. Corroborating these findings, 
the anti-PGL-I seropositivity of contacts of leprosy cases 
were much higher than reported in our previous study in a 
hyperendemic region of CE (Frota et al. 2010).
Even though our study demonstrated that C and Co 
did not differ in the positivity of RLEP PCR in nasal sam-
ples we encourage testing of nasal swabs among cases, 
contacts and noncontacts of cases in areas where cases 
live, since positive noncases are more likely to turn into 
a case. The World Health Organization proposes clinical 
diagnosis as a main strategy to identify cases. Given the 
difficulties of clinical diagnosis and the failure of this cur-
rent strategy, at least in Brazil, the molecular techniques 
we report here show real promise. Our results would ar-
gue that collecting and testing nasal swabs could be an 
important strategy for identifying cases and carriers in the 
population living in hyperendemic clusters where cases 
are concentrated. Although nasal carriage does not nec-
essarily imply infection or excretion of bacilli, our find-
ings support the hypothesis that in endemic areas like 
Fortaleza, M. leprae is disseminated among the general 
population. As molecular epidemiology techniques be-
come cheaper these active surveillance procedures might 
finally achieve the goals of leprosy control promised by 
the advent of therapies more than 50 years ago.
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